Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations.

Werness BA, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, Dicioccio RA, Tsukada Y, Ponder BA, Piver MS.

Hum Pathol. 2000 Nov;31(11):1420-4.

PMID:
11112219
2.

Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry.

Werness BA, Ramus SJ, DiCioccio RA, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, Tsukada Y, Harrington P, Gayther SA, Ponder BA, Piver MS.

Int J Gynecol Pathol. 2004 Jan;23(1):29-34.

PMID:
14668547
3.

Primary ovarian dysgerminoma in a patient with a germline BRCA1 mutation.

Werness BA, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio RA, Tsukada Y, Ponder BA, Piver MS.

Int J Gynecol Pathol. 2000 Oct;19(4):390-4.

PMID:
11109172
4.
5.

Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer.

Schorge JO, Mahoney NM, Miller DS, Coleman RL, Muller CY, Euhus DM, Tomlinson GE.

Gynecol Oncol. 2001 Nov;83(2):383-7.

PMID:
11606101
6.

Childhood cancer in families with and without BRCA1 or BRCA2 mutations ascertained at a high-risk breast cancer clinic.

Brooks GA, Stopfer JE, Erlichman J, Davidson R, Nathanson KL, Domchek SM.

Cancer Biol Ther. 2006 Sep;5(9):1098-102. Epub 2006 Sep 11.

PMID:
16931905
7.

Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.

Werness BA, Parvatiyar P, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio RA, Wiest J, Tsukada Y, Ponder BA, Piver MS.

J Natl Cancer Inst. 2000 Jul 5;92(13):1088-91.

PMID:
10880552
9.

Hereditary ovarian cancer.

Prat J, Ribé A, Gallardo A.

Hum Pathol. 2005 Aug;36(8):861-70. Review.

PMID:
16112002
10.

BRCA1 mutations in Taiwanese with epithelial ovarian carcinoma and sporadic primary serous peritoneal carcinoma.

Wang PH, Shyong WY, Li YF, Lee HH, Tsai WY, Chao HT, Wu CY, Tsai YC, Yuan CC.

Jpn J Clin Oncol. 2000 Aug;30(8):343-8.

PMID:
11059339
11.

Pathology of ovarian cancers in BRCA1 and BRCA2 carriers.

Lakhani SR, Manek S, Penault-Llorca F, Flanagan A, Arnout L, Merrett S, McGuffog L, Steele D, Devilee P, Klijn JG, Meijers-Heijboer H, Radice P, Pilotti S, Nevanlinna H, Butzow R, Sobol H, Jacquemier J, Lyonet DS, Neuhausen SL, Weber B, Wagner T, Winqvist R, Bignon YJ, Monti F, Schmitt F, Lenoir G, Seitz S, Hamman U, Pharoah P, Lane G, Ponder B, Bishop DT, Easton DF.

Clin Cancer Res. 2004 Apr 1;10(7):2473-81.

12.

Histopathologic features of genetically determined ovarian cancer.

Shaw PA, McLaughlin JR, Zweemer RP, Narod SA, Risch H, Verheijen RH, Ryan A, Menko FH, Kenemans P, Jacobs IJ.

Int J Gynecol Pathol. 2002 Oct;21(4):407-11.

PMID:
12352190
13.

Clinical features of familial ovarian cancer lacking mutations in BRCA1 or BRCA2.

Menkiszak J, Gronwald J, Górski B, Byrski T, Huzarski T, Jakubowska A, Foszczyńska-Kłoda M, Brzosko M, Fliciński J, Rzepka-Górska I, Narod SA, Lubiński J.

Eur J Gynaecol Oncol. 2004;25(1):99-100.

PMID:
15053073
14.

BRCA1 and BRCA2 mutations among Finnish ovarian carcinoma families.

Sarantaus L, Auranen A, Nevanlinna H.

Int J Oncol. 2001 Apr;18(4):831-5.

PMID:
11251181
15.

High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in Poland.

Brozek I, Ochman K, Debniak J, Morzuch L, Ratajska M, Stepnowska M, Stukan M, Emerich J, Limon J.

Gynecol Oncol. 2008 Feb;108(2):433-7. Epub 2007 Nov 7.

PMID:
17997147
16.
17.

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.

Pal T, Permuth-Wey J, Betts JA, Krischer JP, Fiorica J, Arango H, LaPolla J, Hoffman M, Martino MA, Wakeley K, Wilbanks G, Nicosia S, Cantor A, Sutphen R.

Cancer. 2005 Dec 15;104(12):2807-16.

18.

A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.

Machácková E, Foretová L, Navrátilová M, Valík D, Claes K, Messiaen L.

Cas Lek Cesk. 2000 Oct 11;139(20):635-7.

PMID:
11192759
19.

The presence of hereditary BRCA1 gene mutations in women with familial breast or ovarian cancer and the frequency of occurrence of these tumours in their relatives.

Skasko E, Paszko Z, Niwińska A, Kwiatkowska E, Kruczek A, Pieńkowski T.

Eur J Gynaecol Oncol. 2004;25(4):470-4.

PMID:
15285306
20.

Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1.

Rubin SC, Benjamin I, Behbakht K, Takahashi H, Morgan MA, LiVolsi VA, Berchuck A, Muto MG, Garber JE, Weber BL, Lynch HT, Boyd J.

N Engl J Med. 1996 Nov 7;335(19):1413-6.

Supplemental Content

Support Center